United States
Print page content Print
Increase text size Decrease text size
Text Size

Thank you for 20 years of helping us make a difference to more than 24 million dogs1

RIMADYL® (carprofen) is the #1 veterinarian-recommended non-steroidalanti-inflammatory drug (NSAID) for pain relief for osteoarthritis. More than 24 million dogs have been treated with RIMADYL since 1996.1,2 In fact, more dogs have been treated with RIMADYL than all other NSAIDs combined.1

The Original NSAID (US)
  • The first FDA-approved NSAID for dogs with osteoarthritis
  • Backed by 20 years of research and science, with more than 100 peer-reviewed articles confirming safety and efficacy
RIMADYL Chewables & Caplets
  • Flexible once- or twice-daily dosing administered by the owner
  • RIMADYL chewable is highly palatable and was readily accepted by >93% of dogs2
  • Reliable quality and US-based supply
RIMADYL Injectable
  • Given preoperatively to reduce postoperative pain
  • Pre-emptive analgesic administered only by a veterinarian
RIMADYL Rewards Program
  • Encourages clients to sustain long-term care and return to your practice
  • Gives pet owners significant savings on products and services
Veterinary Medical Information and Product Support
  • Provides veterinarians and pet owners with superior medical, technical and product informational support from a team of experts
  • Available on your mobile device via the new V-KNOW App

Contact VMIPS toll-free at 1-888-ZOETIS1 (963-8471), or visit www.zoetisus.com/vmips.


As a class, NSAIDs may be associated with gastrointestinal, kidney and liver side effects. These are usually mild, but may be serious. Pet owners should discontinue therapy and contact their veterinarian immediately if side effects occur. Evaluation for pre-existing conditions and regular monitoring are recommended for pets on any medication, including RIMADYL. Use with other NSAIDs or corticosteroids should be avoided. See full Prescribing Information, attached here.

  1. Zoetis US NSAID Market Data, December 2015.
  2. Payne-Johnson M, Maitland TP, Bullard J, Gosselin J. Comparative palatability of three commercial formulations of carprofen and one commercial formulation of firocoxib in dogs. Revue Méd Vét. 2006;157(8-9):431-440.

This site is intended for U.S. Animal Healthcare Professional. The product information provided in this site is intended only for residents of the United States. The products discussed herein may not have marketing authorization or may have different product labeling in different countries. The animal health information contained herein is provided for educational purposes only and is not intended to replace discussions with an animal healthcare professional. All decisions regarding the care of a veterinary patient must be made with an animal healthcare professional, considering the unique characteristics of the patient.

All trademarks are the property of Zoetis Services LLC or a related company or a licensor unless otherwise noted. © 2017 Zoetis Services LLC. All rights reserved. RIM-00195